These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

549 related items for PubMed ID: 16953276

  • 1. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity.
    Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, Tona F, Iliceto S, Pengo V.
    Thromb Haemost; 2006 Sep; 96(3):337-41. PubMed ID: 16953276
    [Abstract] [Full Text] [Related]

  • 2. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.
    Ruffatti A, Tonello M, Cavazzana A, Bagatella P, Pengo V.
    Thromb Res; 2009 Sep; 123(3):482-7. PubMed ID: 18462781
    [Abstract] [Full Text] [Related]

  • 3. Antibody profiles for the diagnosis of antiphospholipid syndrome.
    Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S.
    Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]

  • 5. Thrombophilic dimension of recurrent fetal loss in Indian patients.
    Vora S, Shetty S, Ghosh K.
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):581-4. PubMed ID: 18685442
    [Abstract] [Full Text] [Related]

  • 6. Thrombophilia and unexplained pregnancy loss in Indian patients.
    Vora S, Shetty S, Salvi V, Satoskar P, Ghosh K.
    Natl Med J India; 2008 Sep; 21(3):116-9. PubMed ID: 19004141
    [Abstract] [Full Text] [Related]

  • 7. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V, Bison E, Ruffatti A, Iliceto S.
    Thromb Res; 2008 Sep; 122(4):556-9. PubMed ID: 18328538
    [Abstract] [Full Text] [Related]

  • 8. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.
    Gris JC, Quéré I, Sanmarco M, Boutiere B, Mercier E, Amiral J, Hubert AM, Ripart-Neveu S, Hoffet M, Tailland ML, Rousseau O, Monpeyroux F, Dauzat M, Sampol J, Daures JP, Berlan J, Marès P.
    Thromb Haemost; 2000 Aug; 84(2):228-36. PubMed ID: 10959694
    [Abstract] [Full Text] [Related]

  • 9. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V, Banzato A, Bison E, Denas G, Padayattil Jose S, Ruffatti A.
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [Abstract] [Full Text] [Related]

  • 10. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
    Galli M.
    Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
    [Abstract] [Full Text] [Related]

  • 11. [Laboratory examinations in antiphospholipid syndrome].
    Ieko M, Naito S, Yoshida M.
    Rinsho Byori; 2010 Apr; 58(4):343-51. PubMed ID: 20496762
    [Abstract] [Full Text] [Related]

  • 12. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 13. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis.
    Opatrny L, David M, Kahn SR, Shrier I, Rey E.
    J Rheumatol; 2006 Nov; 33(11):2214-21. PubMed ID: 17014001
    [Abstract] [Full Text] [Related]

  • 14. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A, Kickler TS, Petri M.
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [Abstract] [Full Text] [Related]

  • 15. Anti-β2 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome.
    Liu XL, Xiao J, Zhu F.
    Acta Obstet Gynecol Scand; 2013 Feb; 92(2):234-7. PubMed ID: 23157457
    [Abstract] [Full Text] [Related]

  • 16. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, Llurba-Olive E, Hermosilla E, Vilardell-Tarres M, Cabero-Roura L.
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [Abstract] [Full Text] [Related]

  • 17. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.
    Martinuzzo ME, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO.
    J Rheumatol; 1998 Jul; 25(7):1313-9. PubMed ID: 9676762
    [Abstract] [Full Text] [Related]

  • 18. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
    Cojocaru IM, Cojocaru M, Tănăsescu R, Burcin C, Mitu AC, Iliescu I, Dumitrescu L, Pavel I, Silosi I.
    Rom J Intern Med; 2008 Jul; 46(4):337-41. PubMed ID: 19480300
    [Abstract] [Full Text] [Related]

  • 19. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Jul; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 20. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.